HEALTH CATALYST INC (HCAT) Stock Price & Overview
NASDAQ:HCAT • US42225T1079
Current stock price
The current stock price of HCAT is 1.215 USD. Today HCAT is down by -7.95%. In the past month the price decreased by -33.97%. In the past year, price decreased by -72.45%.
HCAT Key Statistics
- Market Cap
- 89.412M
- P/E
- 6.39
- Fwd P/E
- 3.33
- EPS (TTM)
- 0.19
- Dividend Yield
- N/A
HCAT Stock Performance
HCAT Stock Chart
HCAT Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to HCAT. When comparing the yearly performance of all stocks, HCAT is a bad performer in the overall market: 97.02% of all stocks are doing better.
HCAT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HCAT. HCAT has a bad profitability rating. Also its financial health evaluation is rather negative.
HCAT Earnings
On March 12, 2026 HCAT reported an EPS of 0.08 and a revenue of 74.68M. The company missed EPS expectations (-13.81% surprise) and missed revenue expectations (-1.04% surprise).
HCAT Forecast & Estimates
17 analysts have analysed HCAT and the average price target is 3.95 USD. This implies a price increase of 225.31% is expected in the next year compared to the current price of 1.215.
For the next year, analysts expect an EPS growth of 91.99% and a revenue growth -2.85% for HCAT
HCAT Groups
Sector & Classification
HCAT Financial Highlights
Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -32.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.41% | ||
| ROE | -72.41% | ||
| Debt/Equity | 0.62 |
HCAT Ownership
HCAT Latest News, Press Relases and Analysis
HCAT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 21.16 | 30.456B | ||
| WAY | WAYSTAR HOLDING CORP | 14.9 | 4.717B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.81 | 4.542B | ||
| HTFL | HEARTFLOW INC | N/A | 1.787B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.112B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 230.17 | 1.097B | ||
| CERT | CERTARA INC | 12.94 | 1.033B | ||
| TDOC | TELADOC HEALTH INC | N/A | 961.576M | ||
| SDGR | SCHRODINGER INC | N/A | 937.641M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 6.05 | 760.505M | ||
| PHR | PHREESIA INC | 16.89 | 662.587M | ||
| HSTM | HEALTHSTREAM INC | 27.41 | 615.679M | ||
| EVH | EVOLENT HEALTH INC - A | 11.12 | 337.153M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HCAT
Company Profile
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Company Info
IPO: 2019-07-25
HEALTH CATALYST INC
10897 South River Front Parkway, #300
South Jordan UTAH 84121 US
CEO: Daniel Burton
Employees: 0
Phone: 18017086800
HEALTH CATALYST INC / HCAT FAQ
What does HCAT do?
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Can you provide the latest stock price for HEALTH CATALYST INC?
The current stock price of HCAT is 1.215 USD. The price decreased by -7.95% in the last trading session.
What is the dividend status of HEALTH CATALYST INC?
HCAT does not pay a dividend.
What is the ChartMill rating of HEALTH CATALYST INC stock?
HCAT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is HEALTH CATALYST INC (HCAT) stock traded?
HCAT stock is listed on the Nasdaq exchange.
Would investing in HEALTH CATALYST INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HCAT.
What is the Short Interest ratio of HEALTH CATALYST INC (HCAT) stock?
The outstanding short interest for HEALTH CATALYST INC (HCAT) is 10.06% of its float.